Circulating follistatin in the human foetus at term birth

Pediatric Obesity

Volumn 7, Issue 1, 2012, Pages 39-43

  Sebastiani, G ^a,b   Diaz M ^a,b   Lopez Bermejo A ^c,d   Arranz, A ^a   De Zegher, F ^e   Ibáñez, Lourdes ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adipogenesis; Birthweight; Body composition; Follistatin

Indexed keywords

FOLLISTATIN; INSULIN;

ADIPOGENESIS; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SERUM; SMALL FOR DATE INFANT; TERM BIRTH; UMBILICAL CORD BLOOD; BLOOD; CHEMISTRY; FETUS BLOOD; FETUS DEVELOPMENT; METABOLISM; PHYSIOLOGY; PREGNANCY;

BIRTH WEIGHT; BODY COMPOSITION; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; FOLLISTATIN; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; MALE; PREGNANCY;

EID: 84860656043     PISSN: 20476310     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2047-6310.2011.00004.x     Document Type: Article

References (17)

1. Hammami M, Koo WW, Hockman EM. Body composition of neonates from fan beam dual energy X-ray absorptiometry measurement. JPEN J Parenter Enteral Nutr 2003; 27: 423-426. (Pubitemid 38133107)
2. Shields BM, Knight B, Hopper H, et al. Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care 2007; 30: 2661-2666. (Pubitemid 47547817)
3. Ibáñez L, Sebastiani G, Diaz M, López-Bermejo A, Gómez-Roig MD, de Zegher F. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin and IGF-I at term birth: relation to prenatal growth. J Clin Endocrinol Metab 2008; 93: 2774-2778. (Pubitemid 352008550)
4. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35 000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci U S A 1987; 84: 8282-8286.
5. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 2009; 297: E157-E164.
6. Gajos-Michniewicz A, Piastowska AW, Russell JA, Ochedalski T. Follistatin as a potent regulator of bone metabolism. Biomarkers 2010; 15: 563-574.
7. Kawabata N, Kamiya N, Suzuki N, Matsumoto M, Takagi M. Changes in extracellular activin A: follistatin ratio during differentiation of a mesenchymal progenitor cell line, ROB-C26 into osteoblasts and adipocytes. Life Sci 2007; 81: 8-18. (Pubitemid 46891500)
8. Flanagan JN, Linder K, Mejhert N, et al. Role of follistatin in promoting adipogenesis in women. J Clin Endocrinol Metab 2009; 94: 3003-3009.
9. Lee SJ, Lee YS, Zimmers TA, et al. Regulation of muscle mass by follistatin and activins. Mol Endocrinol 2010; 24: 1998-2008.
10. Ibáñez L, López-Bermejo A, Díaz M, Jaramillo A, Marín S, de Zegher F. Growth hormone therapy in short children born small-for-gestational-age: effects on abdominal fat partitioning and on circulating follistatin and high-molecular-weight adiponectin. J Clin Endocrinol Metab 2010; 95: 2234-2239.
11. Ibáñez L, Sebastiani G, Diaz M, Gómez-Roig MD, López-Bermejo A, de Zegher F. Low body adiposity and high leptinemia in breast-fed infants born small-for-gestational- age. J Pediatr 2010; 156: 145-147.
12. Ferrández-Longás A, Mayayo E, Labarta JI, et al. Estudio longitudinal de crecimiento y desarrollo. Centro Andrea Prader. Zaragoza 1980-2002. In: ERGON (ed.). Patrones de crecimiento y desarrollo en España. Atlas de gráficas y tablas: Madrid, Spain, 2004, 61-115.
13. Ibáñez L, Díaz M, López-Bermejo A, de Zegher F. Divergent effects of ethinyl-estradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess. Gynecol Endocrinol 2011; 27: 197-198.
14. O'Connor AE, McFarlane JR, Hayward S, Yohkaichiya T, Groome NP, de Kretser DM. Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod 1999; 14: 827-832. (Pubitemid 29131271)
15. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 2006; 147: 3586-3597. (Pubitemid 43901151)
16. Mukherjee A, Sidis Y, Mahan A. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A 2007; 104: 1348-1353. (Pubitemid 46184007)
17. Szabat M, Johnson JD, Piret JM. Reciprocal modulation of adult beta cell maturity by activin and follistatin. Diabetologia 2010; 53: 1680-1689.